182 related articles for article (PubMed ID: 17207956)
21. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
[TBL] [Abstract][Full Text] [Related]
22. Sentinel node biopsy for melanoma: an update after two decades of experience.
Ross MI
Semin Cutan Med Surg; 2010 Dec; 29(4):238-48. PubMed ID: 21277537
[TBL] [Abstract][Full Text] [Related]
23. Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanoma.
Chai CY; Zager JS; Szabunio MM; Marzban SS; Chau A; Rossi RM; Sondak VK
Ann Surg Oncol; 2012 Apr; 19(4):1100-6. PubMed ID: 22193886
[TBL] [Abstract][Full Text] [Related]
24. Twelve years' experience of sentinel lymph node biopsy for melanoma at a rural New Zealand hospital.
Sakowska MM; Smith N; Coutts RJ
N Z Med J; 2014 Jun; 127(1395):12-22. PubMed ID: 24929689
[TBL] [Abstract][Full Text] [Related]
25. Sentinel node biopsy in cutaneous melanoma.
Lock-Andersen J; Horn J; Sjøstrand H; Nürnberg BM; Stokholm KH
Scand J Plast Reconstr Surg Hand Surg; 2006; 40(1):24-31. PubMed ID: 16428210
[TBL] [Abstract][Full Text] [Related]
26. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients.
Howman-Giles R; Shaw HM; Scolyer RA; Murali R; Wilmott J; McCarthy SW; Uren RF; Thompson JF
Ann Surg Oncol; 2010 Jan; 17(1):138-43. PubMed ID: 19672660
[TBL] [Abstract][Full Text] [Related]
27. PET vs sentinel lymph node biopsy for staging melanoma: a patient intervention, comparison, outcome analysis.
El-Maraghi RH; Kielar AZ
J Am Coll Radiol; 2008 Aug; 5(8):924-31. PubMed ID: 18657789
[TBL] [Abstract][Full Text] [Related]
28. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
Horn J; Lock-Andersen J; Sjøstrand H; Loft A
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):887-92. PubMed ID: 16586078
[TBL] [Abstract][Full Text] [Related]
29. New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB).
Ulrich J; van Akkooi AJ; Eggermont AM; Voit C
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1693-701. PubMed ID: 22050018
[TBL] [Abstract][Full Text] [Related]
30. Baseline staging in cutaneous malignant melanoma.
Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
[TBL] [Abstract][Full Text] [Related]
31. Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy.
Lin D; Franc BL; Kashani-Sabet M; Singer MI
Head Neck; 2006 Mar; 28(3):249-55. PubMed ID: 16470744
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in patients with thin melanomas.
Cecchi R; Buralli L; Innocenti S; De Gaudio C
J Dermatol; 2007 Aug; 34(8):512-5. PubMed ID: 17683380
[TBL] [Abstract][Full Text] [Related]
33. The value of sentinel node mapping for staging melanoma.
Dijkstra B; Hill A; Kelly L; Prendegast M; McDermott E; O'Donnell M; Collins C; O'Higgins N
Ir Med J; 2001; 94(7):210-2. PubMed ID: 11693212
[TBL] [Abstract][Full Text] [Related]
34. Role of high-resolution ultrasound and PET/CT imaging for preoperative characterization of sentinel lymph nodes in cutaneous melanoma.
Hinz T; Voth H; Ahmadzadehfar H; Hoeller T; Wenzel J; Bieber T; Schmid-Wendtner MH
Ultrasound Med Biol; 2013 Jan; 39(1):30-6. PubMed ID: 23122637
[TBL] [Abstract][Full Text] [Related]
35. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
[TBL] [Abstract][Full Text] [Related]
36. Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.
Homolak D; Vucetić B; Puljiz Z; Blajć I; Vurnek Zivković M; Situm M
Coll Antropol; 2008 Oct; 32 Suppl 2():57-60. PubMed ID: 19138008
[TBL] [Abstract][Full Text] [Related]
37. The role of preoperative positron emission tomography/computed tomography (PET/CT) in patients with high-risk melanoma.
Barsky M; Cherkassky L; Vezeridis M; Miner TJ
J Surg Oncol; 2014 Jun; 109(7):726-9. PubMed ID: 24375280
[TBL] [Abstract][Full Text] [Related]
38. Desmoplastic and neurotropic melanoma.
Su LD; Fullen DR; Lowe L; Wang TS; Schwartz JL; Cimmino VM; Sondak VK; Johnson TM
Cancer; 2004 Feb; 100(3):598-604. PubMed ID: 14745878
[TBL] [Abstract][Full Text] [Related]
39. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node mapping in the management of high risk malignant melanoma.
Donckier V; Vereecken P; Blocklet D; Laporte M; Velu T; Heenen M; Van Geertruyden J
Acta Chir Belg; 1999 Dec; 99(6):295-8. PubMed ID: 10674132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
